Mylan stock: buy or sell?
May 21st, 2019
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter products worldwide.
Should I buy Mylan stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Following a trading strategy helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Mylan stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Mylan stock a buy?
Financial institutions and banks post stock ratings everyday.At Stocks2.com, we detected 14 ratings published for MYL stock in the last 30 days. The general sentiment of these ratings is bullish for MYL stock, with 10 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-5-8||Royal Bank of Canada||n/a||Outperform|
|2019-3-6||Morgan Stanley||Equal Weight||Overweight|
|2019-3-6||Credit Suisse Group||n/a||Buy|
|2019-2-27||Wells Fargo & Co||n/a||Outperform|
|2019-2-27||Sanford C. Bernstein||Outperform||Market Perform|
|2019-2-27||BMO Capital Markets||n/a||Outperform|
Mylan stock analysis
Shares of Mylan closed today at $19.67 and inched a decent 1.29%.
Shares of Mylan inched a decent 1.29% and closed at $19.67.
After sliding a scary -12.88% in a week last week, Mylan closed this week at $19.67 and stayed steady a neutral 0.15%.
Mylan finally declined through the support line and now is sliding further looking for new supports. Since price and 40-weeks moving average lines crossed down by mid June 2018, MYL fell $-21.69 per share (-52.44%). Stocks under the 40-weeks moving average line are usually not recommended for average traders.
Mylan stock price history
Mylan IPO was on March 17th, 1980 at $0.92 per share1. Since then, MYL stock surged a 2,038.00%, with a yearly average of 52.30%. If you had invested $1,000 in Mylan stock in 1980, it would worth $20,380.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Mylan stock historical price chart
MYL stock reached 52-week highs on June at $42.50, and all-time highs 2015-04-24 with a price of 76.69.
Mylan stock price target is $33.10How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. We found 11 price predictions for Mylan stock published in the last 30 days:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-5-8||Royal Bank of Canada||Lowers Target||n/a||$26.00||-|
|2019-5-8||Raymond James||Set Price Target||n/a||$31.00||-|
|2019-5-8||Morgan Stanley||Set Price Target||n/a||$32.00||-|
|2019-3-6||Credit Suisse Group||Reiterates||n/a||$37.00||-|
|2019-2-27||Wells Fargo & Co||Reiterates||$40.00||$33.00||-17.5%|
|2019-2-27||BTIG Research||Lowers Target||n/a||$35.00||-|
|2019-2-27||BMO Capital Markets||Raises Target||n/a||$40.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, Mylan presented its financial report, in line with analysts' consensus and published a $1.30 Earnings per Share. As soon as we get its posted EPS from the earnings report, we will update this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Mylan annual revenues declined a rough -3.98% to $11,433.90 M USD from $11,907.70 marked in 2017. When comparing 2018 vs 2017, likewise, profit margin (that is, the net income divided by revenues) depreciated a -2.76% to 3.08%.
|2013||$6,970 M||-||$624 M8.9%||-|
|2014||$7,720 M||10.75%||$929 M12.0%||49.01%|
|2015||$9,429 M||22.15%||$848 M9.0%||-8.80%|
|2016||$11,077 M||17.47%||$480 M4.3%||-43.37%|
|2017||$11,908 M||7.50%||$696 M5.8%||45.00%|
|2018||$11,434 M||-3.98%||$353 M3.1%||-49.35%|
Quarterly financial resultsMylan reported $3,078.70 M in revenues for 2018-Q4, a 7.56% improvement compared to previous quarter. Reported quarter earnings marked $51.20 M with a profit margin of 1.66%. Profit margin slightly fell a -4.51% compared to previous quarter when profit margin was 6.17%. When comparing revenues to same quarter last year, Mylan sales marked a fatal decrease and decreased a -4.95%. Looking back to recent quarterly results, Mylan posted 3 positive quarters in a row.
|2017-Q1||$2,720 M||-||$66 M2.4%||-|
|2017-Q2||$2,960 M||8.82%||$297 M10.0%||347.29%|
|2017-Q3||$2,987 M||0.92%||$88 M3.0%||-70.27%|
|2017-Q4||$3,239 M||8.43%||$244 M7.5%||176.67%|
|2018-Q1||$2,685 M||-17.12%||$87 M3.2%||-64.35%|
|2018-Q2||$2,808 M||4.61%||$38 M1.3%||-56.95%|
|2018-Q3||$2,862 M||1.93%||$177 M6.2%||371.20%|
|2018-Q4||$3,079 M||7.56%||$51 M1.7%||-71.02%|
Mylan ownershipWhen you are planning to invest in a stock, it's worth to review its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Mylan, 1.08% of all outstanding shares are owned by its staff.
Bearish positions for MYL stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Mylan:
|Market cap||$10.1 B||$235.9 M||$230.8 B||$6.1 B||$51.8 B|
|Total shares||515.4 M||39.3 M||5,550.0 M||166.0 M||1,250.0 M|
|Float shares||513.0 M||26.6 M||5,520.0 M||120.8 M||2,210.0 M|
|- Institutional holdings (%)||86.2%||86.6%||76.2%||13.6%||7.7%|
|- Insider holdings (%)||1.1%||28.2%||0.0%||0.0%||0.0%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Tuesday, May 21st, 2019|
|Day range||$19.45 - $19.97|
|Average true range||$1.39|
|50d mov avg||$26.08|
|100d mov avg||$27.69|
|200d mov avg||$31.28|
Mylan performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We compared Mylan against Lannett, Pfizer, Dr. Reddy's Laboratories, and Teva Pharmaceutical Industries in the following table:
|RDYDr. Reddy's L...||0.35%||0.03%||28.24%|
Mylan competitorsOne check before trading any stock is to have a look a list of its competitors, in this case for Mylan. We chose 5 companies as Mylan competitors as they are in the same industry or have similar market objectives.
Latest Mylan stock news
- Investors.comChina Trade War Questions Undercut Stock Futures; Mylan, Teva Dive On ChargesMay 13, 2019
- InvestorPlace3 Big Stock Charts for Monday: American Airlines Group, Mylan and CelgeneMay 6, 2019
- Seeking AlphaWhy Mylan Shares Will Rebound This YearMarch 5, 2019
- InvestorPlaceMylan Stock May Fall Further After Hitting 52-Week LowsFebruary 28, 2019
- Seeking AlphaMylan: Is It Still A Cyclical Value?January 22, 2019